Issue 29

26.01.2018

Our International Cannabis Weekly newsletter brings you the latest international cannabis developments across business, regulation and science. All past issues are now available here where you can read the stories that have helped shape the international cannabis industry over the past year.

View All

Business & Investment

Regulation & Politics

Health & Science

Note – Prohibition Partners will be attending NIMCS 2018 this coming Saturday in Belfast.

Market Focus

SERBIAN PATIENTS FIGHT FOR CANNABIS REFORM

Serbia is  the largest and most populous country of the former Yugoslavia. It is home to a strong pro-legalisation movement which is led by activists, patients and researchers. In this case, that opposing force is spearheaded by far-right parties and conservative medical groups who desperately cling to ill-informed stigmas surrounding cannabis.

As part of the Prohibition Partners European Country Review, we examine what divides opinion on cannabis legislation and how far they have come on the bumpy road to modernisation.

 

 

Medical Cannabis in Europe - The GMP Standards Guide

Prohibition Partners is excited to announce the launch of Medical Cannabis in Europe. The GMP Standards Guide, in association with Orion GMP Solutions.

If Europe wants to become global leaders in the cannabis industry, ensuring that it adheres to the highest manufacturing practices is essential. The GMP Standards Guide is intended to be used as a reference by manufacturers, legislators and all involved in the European cannabis industry to educate on best practice and international legislation.

The report is due to be released in February 2018 but you can read a short extract here.

 

The European Cannabis Report

 

news

intelligence

Market Insight

on the cannabis market

Our weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry.

We will only email you once every week.